SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Talk to Advisor
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

Amkay Products Ltd (544169)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 544169 NSE: Medical Equipment/Supplies/Accessories | Small Cap | Amkay Products Share Price

₹55.50 0.00 (0.00%)

As on 02-Jun'26 16:59

Amkay Products Ltd (544169)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 544169 NSE: Medical Equipment/Supplies/Accessories | Small Cap | Amkay Products Share Price

₹55.50 0.00 (0.00%)

As on 02-Jun'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹48 Cr.
Current Price
₹55.5
52-Week Low / High
₹39 / 82
TTM EPS
₹2.7
TTM Sales
₹42 Cr.
Book Value per Share
₹27.8
P/E Ratio
20.79
Higher than its 5-year historical median
Industry PE
111.2
Price to Book (P/B)
2.00
Lower than its 5-year historical median
Price to Sales (P/S)
1.14
Lower than its 5-year historical median
EV/EBITDA
10.88
In line with its 5-year historical median
Dividend Yield
0.00%
Profitability Efficiency
Return on Equity (ROE)
19.60%
Outperforms industry median
Return on Capital Employed (ROCE)
21.89%
Outperforms industry median
Return on Assets (ROA)
14.10%
Operating Profit Margin
10.7%
Net Profit Margin
8.7%
Gross Profit Margin
13.4%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
23.56%
Operating Profit Growth (1 Year)
Improving versus 3-year growth rate
24.02%
Net Profit Growth (1 Year)
Slowing versus 3-year growth rate
27%
Asset Quality
Promoter Holding
73.44%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹15 Cr.
Equity
₹8.7 Cr.
Face Value
₹10
All Time Low / High
₹36.00 / 120.96

Amkay Products stock performance

Key Ratios
mw4me loader

Check Before You Invest

Check Before You Invest

M-Cap below 100cr DeciZen not available

Q.1 Is Amkay Products Ltd a good quality company?
Amkay Products Ltd is a quality company, based on a multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

View More

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

View More
How does Amkay Products Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Amkay Products Ltd vs industry peers?
Amkay Products Ltd revenue CAGR is 0.00%, compared to the industry median CAGR of 0%, indicating stable growth and maintaining its market share.
Q.1 Promoter shareholding and pledge status of Amkay Products Ltd?
Promoters hold 73.44% of the Amkay Products Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Amkay Products Ltd over the last decade?
Over the last 1 year(s), the stock has delivered a CAGR of 35.56% based on the current price.
View More

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Amkay Products Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation ⓘ

Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % ⓘ71.9%29.3%24.7%28.8%21.9%-
Value Creation
Index ⓘ		4.11.10.81.10.6-

Growth Parameters ⓘ
Sales ⓘ40.736.527.931.138.442
Sales YoY Gr.--10.3%-23.7%11.5%23.6%-
Adj EPS ⓘ52.32.44.13.82.7
YoY Gr.--53.6%3%73.5%-8%-
BVPS (₹) ⓘ7.59.812.215.727.827.8
Adj Net
Profit ⓘ		3.21.51.52.63.32
Cash Flow from Ops. ⓘ3.4-0.31-0.7-0.3-
Debt/CF from Ops. ⓘ0.4-17.34.8-8.3-8.3-

CAGR ⓘ

9 Years 5 Years 3 Years 1 Years
Sales ⓘNANA1.7%23.6%
Adj EPS ⓘNANA18.1%-8%
BVPSⓘNANA41.8%76.8%
Share Price - - - 32.8%

Key Financial Parameters ⓘ

Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity % ⓘ		66.926.821.829.719.39.6
Op. Profit
Mgn % ⓘ		11.47.411.410.710.8NAN
Net Profit
Mgn % ⓘ		7.845.48.58.65.5
Debt to
Equity ⓘ		0.30.70.60.60.1-
Working Cap
Days ⓘ		0781141241400
Cash Conv.
Cycle ⓘ		0-62662880

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'21Mar'22Mar'23Mar'24Mar'25
Sales40.7036.5027.8631.0738.39
Operating Expenses ⓘ + 36.1133.8224.7027.7434.26
Manufacturing Costs2.072.081.171.491.80
Material Costs25.3425.7818.0822.1226.24
Employee Cost 5.234.584.292.412.97
Other Costs ⓘ 3.481.371.151.723.25
Operating Profit ⓘ 4.592.693.173.334.13
Operating Profit Margin (%) 11.3%7.4%11.4%10.7%10.7%
Other Income ⓘ + 0.080.290.391.251.32
Exceptional Items ⓘ 00000
Interest ⓘ 0.210.410.500.520.32
Depreciation ⓘ 0.280.540.710.560.83
Profit Before Tax ⓘ 4.182.042.343.504.30
Tax ⓘ 1.050.570.810.870.96
Profit After Tax 3.131.471.532.633.34
PAT Margin (%) 7.7%4.0%5.5%8.5%8.7%
Adjusted EPS (₹)4.92.32.44.13.9
Dividend Payout Ratio (%)0%0%0%0%0%

Valuation of Amkay Products - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 4.746.217.741024.07
Share Capital ⓘ 0.280.280.286.368.66
Reserves ⓘ 4.465.937.463.6415.41
Debt +1.374.324.375.012.13
Long Term Debt1.353.473.351.281.05
Short Term Debt0.020.851.023.741.09
Minority Interest00000
Trade Payables5.744.552.492.062.62
Others Liabilities ⓘ 1.790.491.020.660.81
Total Liabilities ⓘ 13.6415.5715.6317.7429.63

Fixed Assets

Net Fixed Assets ⓘ +2.303.913.262.584.14
Gross Block6.018.168.158.9011.22
Accumulated Depreciation3.724.254.896.327.09
CWIP ⓘ 00000.12
Investments ⓘ 3.522.793.622.576.85
Inventories0.291.982.615.618.13
Trade Receivables4.093.633.713.996.01
Cash Equivalents 0.920.200.050.111.54
Others Assets ⓘ 2.523.042.392.882.86
Total Assets ⓘ 13.6415.5715.6317.7429.63

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity ⓘ + 3.38-0.250.98-0.66-0.32
PBT ⓘ 4.182.042.343.504.30
Adjustment ⓘ 0.350.770.760.14-0
Changes in Working Capital ⓘ -0.03-2.55-1.52-3.41-3.59
Tax Paid ⓘ -1.12-0.52-0.60-0.90-1.02
Cash Flow From Investing Activity ⓘ + -1.98-3.07-1.390.48-5.84
Capex -1.20-2.15-0.02-0.73-2.48
Net Investments -0.40-1.26-1.570.66-4.28
Others ⓘ -0.380.340.210.550.92
Cash Flow From Financing Activity ⓘ + -0.652.590.260.247.59
Net Proceeds from Shares ⓘ 000012.61
Net Proceeds from Borrowing ⓘ 0.102.12-0.12-2.07-0.23
Interest Paid ⓘ -0.14-0.38-0.45-0.52-0.32
Dividend Paid ⓘ 00000
Others ⓘ -0.610.850.832.84-4.47
Net Cash Flow ⓘ 0.76-0.72-0.150.061.43

Financial Ratio

PARTICULARSMar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)65.9826.812229.6519.6
ROCE (%)71.9129.3224.7328.8421.89
Asset Turnover Ratio2.982.51.791.861.62
PAT to CFO Conversion(x)1.08-0.170.64-0.25-0.1
Working Capital Days
Receivable Days36.7038.6048.1045.2047.50
Inventory Days2.6011.4030.1048.3065.30
Payable Days82.7072.907137.6032.60

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Amkay Products Ltd FAQs

The current trading price of Amkay Products on 02-Jun-2026 16:59 is ₹55.50.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jun-2026 the market cap of Amkay Products stood at ₹48.04 Cr

The latest P/E ratio of Amkay Products as of 01-Jun-2026 is 20.79.

The latest P/B ratio of Amkay Products as of 01-Jun-2026 is 2.00.

The 52-week high of Amkay Products is ₹81.99 and the 52-week low is ₹39.22.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Amkay Products is ₹42.03 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Amkay Products Ltd is a average quality company.

The key valuation ratios of Amkay Products Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Amkay Products Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Amkay Products Ltd

Amkay Products was originally incorporated as ‘Amkay Products Private Limited’ on October 25, 2007 under the provisions of the Companies Act, 1956 with the Registrar of Companies, Maharashtra, Mumbai. Subsequently, pursuant to Special Resolution passed by the Shareholders at the Extra Ordinary General Meeting, held on August 02, 2023, the Company was converted into a Public Limited Company and consequently the name of the Company was changed from ‘Amkay Products Private Limited’ to ‘Amkay Products Limited’ vide a fresh certificate of incorporation consequent upon conversion from private company to public company dated August 28, 2023 issued by the Registrar of Companies, Maharashtra, Mumbai.

It manufactures, assemble & market a comprehensive portfolio of medical devices, disposables and other Healthcare Products like Face Mask, Alcohol Swabs, Lancet Needles, Nebulizer, Pulse Oximeter, surgeon cap etc. used by healthcare centers, hospitals/clinics, nursing homes etc. widely spread across India. In addition, it is also engaged in branding and marketing of some of the products like Diapers, Plastic Gloves, Suction Machines etc. The company started its operations in year 2008 with manufacturing and supply of one product in a manufacturing unit taken on rent at Vasai in Mumbai. Gradually, more products were added to its portfolio & for further product expansion, over the period, it shifted to bigger manufacturing units from where it entered into branding & trading segment also along with manufacturing. The company’s product portfolio comprises of many product including Respiratory Disease Related Medical Devices, Surgical Disposables, Home Healthcare Products and Other Healthcare Products.

Its manufacturing facilities are equipped with requisite infrastructure including machineries, testing laboratory other handling equipment to facilitate smooth manufacturing process. Further, the company has accreditation with ISO 9001:2015 for quality management system from QRO Certification LLP. The company was founded in the year 2007 by one of its Promoters, Kashyap Pravin Mody, who has experience in the associated industry. Later, in 2011, Hemanshu Kantilal Batavia joined the company as Director who has an experience in the said industry. Its promoters are involved in the critical aspects of its business, including expansion, process and plant, finance, sales and marketing. Their understanding of the consumer difficulty, intuitive entrepreneurship and involvement in key aspects of its business has helped accelerate and drive its profitable growth.

Business area of the company 

It manufactures, assemble & market a comprehensive portfolio of medical devices, disposables and other Healthcare Products like Face Mask, Alcohol Swabs, Lancet Needles, Nebulizer, Pulse Oximeter, surgeon cap etc. used by healthcare centers, hospitals/clinics, nursing homes etc. widely spread across India. In addition, it is also engaged in branding and marketing of some of the products like Diapers, Plastic Gloves, Suction Machines etc.

Products of the company

  • Surgical disposables 
  • Home healthcare products 
  • Respiratory disease related medical devices 
  • Other healthcare products

History and milestones

  • 2007: Incorporation of the Company. 
  • 2012: Acquired Manufacturing Unit-I from Spect-Spares vide Deed of Conveyance. 
  • 2016: Acquired Manufacturing Unit-II from Indo Rubber Industries vide Deed of Conveyance September. 
  • 2021-22: Crossed Revenue of Rs 35 crore.
  • 2023: Establishment of additional Warehouse Facility vide Leave and License Agreement.
  • 2023: Conversion of the Company from Private Limited to Public Limited Company.

You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×